Results for tag: "Polypill"

The Polypill market is a subset of the drug delivery industry, focusing on the development and delivery of combination drugs. Polypills are single-dose tablets that contain multiple medications, typically used to treat chronic conditions such as hypertension, diabetes, and cardiovascular disease. The goal of polypills is to simplify medication regimens and improve patient adherence. Polypills are typically developed by pharmaceutical companies and then distributed through pharmacies and other healthcare providers. In recent years, the market has seen an increase in the development of polypills for specific patient populations, such as the elderly or those with multiple chronic conditions. Companies in the Polypill market include Novartis, Pfizer, Merck, and GlaxoSmithKline. Other companies, such as Aurobindo Pharma and Sun Pharmaceuticals, are also active in the market. Show Less Read more